Cairo – Mubasher: Minapharm Pharmaceuticals' consolidated net profits jumped by 75.1% to EGP 352.36 million in the first nine months (9M) of 2021, compared to EGP 201.13 million in the year-ago period.
The company generated revenues of EGP 2.2 billion in the January-September period of 2021, up from EGP 1.65 billion in the same period of 2020, according to a bourse filing on Tuesday.
It is noteworthy to mention that in the first half (H1) of 2021, the company recorded a 96.47% year-on-year (YoY) hike in its consolidated net profits attributable to the company's owners, logging EGP 255.63 million, compared to EGP 130.11 million.
